RNXT - Dana dhuwit perusahaan RenovoRx Corp

Logo grafis renovorx.com (RNXT)

RenovoRx, Inc. (RNXT) is implementing the RenovoTAMP platform for targeted chemotherapy delivery to reduce toxicity. Current cash holdings reflect the dynamics of these expenditures, with the indicator standing at 0.01. While the complexity of certifying hybrid systems is slowing the payback period, a strategic reserve of components ensures stable production of catheters for stomach cancer therapy.

RenovoRx Corp - Dana dhuwit perusahaan RNXT (periode 04.07.2022 - 21.11.2026)

Rincian metrik keuangan lan pasar RenovoRx Corp (RNXT)

- nilai saham lan prakiraan konsensus rega:
Ringkesan analitik perusahaan:RenovoRx, Inc. RNXT
Produk mawa merek RenovoRx Inc

The R&D pipeline development of RenovoRx, Inc. (RNXT) is directly reflected in its volume of highly liquid cash, demonstrating the company's financial runway until the commercialization stage. This indicator aggregates cash and cash equivalents, allowing investors to calculate the burn rate and assess the issuer's ability to fund clinical trials without emergency equity offerings in the absence of stable operating revenue.